beòcarta: biofuels, biotech, biorefineries

global services, global contacts

Since 1985 beòcarta has worked as an R&D consultancy with biomanufacturers in Europe, North America, Japan, India and the Republic of Korea to improve industrial bioprocesses at industrial scale of production:
  • Clavulanic Acid (150,000 L)
  • Penicillins V and G (100,000 – 200,000 L)
  • Lysine (700,000 L)
  • Acarbose (30,000 L)
  • Chlortetracycline (250,000 L)
  • Erythromycin (100,000 L)
  • Vitamin B2 (100,000 L)
  • Avoparcin α (vancomycin-type antibiotic) (50,000 L)
  • Proteases (50,000 – 150,000 L)
  • Amyloglucosidase (50,000 – 150,000 L)
  • Macrolide secondary product bioactives (60,000 – 100,000 L)
  • Rifamycin (90,000 L)
  • Fungal depsipeptide anthelmintic (15,000 L)
  • Lovastatin (10,000 L)
Collaborations have extended to the scale up of novel bioprocesses with bacterial, fungal and animal cell cultures from laboratory (< 1 L) to pilot (1000 L) scales.
Share by: